• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

Emergis and Infoway Complete Preferred Solution Vendor Agreement for Drug Information Systems

Posted on: Thursday, 8 February 2007, 18:01 CST

Emergis Inc. (TSX: EME) announced today that it has concluded a Preferred Solution Agreement with Canada Health Infoway for its Assure EHR Drug Information System (DIS) solution. The three-year Canada-wide agreement includes competitive pricing and conditions designed to accelerate Infoway's program to support the implementation of interoperable electronic health records (EHR) across the country by governments and publicly funded health care organizations. It recognizes that Emergis' DIS solution meets Infoway's criteria from a program investment perspective in terms of pricing and interoperability.

"We are very pleased that Emergis' DIS solution has been recognized by Infoway and are proud to support Infoway's goal of accelerating the adoption of technology to improve the quality and safety of health care for all Canadians," said Mark Groper, Executive Vice-President of Emergis. "We believe this agreement will assist in shortening the sales cycle for DIS projects within Canada and will enhance our position in markets in the U.S. and abroad. Assure EHR Drug Information System has emerged as one of the leading DIS solutions in the market today."

Emergis and Infoway have negotiated pricing for a standard DIS offering to be made available by Emergis to governments and health care organizations. Those wishing to augment or customize the standard offering to suit their particular needs are able to do so. Selection of a specific supplier for a DIS solution rests with the government or health care organization.

Emergis' Assure EHR Drug Information System solution manages clinical data concerning a patient's medication history, including prescribed and dispensed drugs, allergies, and ongoing drug treatment. It allows authorized pharmacists, physicians and other health care professionals to securely exchange relevant and current information to facilitate accurate prescribing and dispensing. Among other features, it supports prescription monitoring programs and increases the efficiency of drug utilization reviews thereby reducing the high human and financial cost of potential adverse drug reactions.

About Infoway

Canada Health Infoway Inc. is an independent not-for-profit organization that invests with public-sector partners across Canada to implement and reuse compatible health information systems which support a safer, more efficient health care system.

About Emergis

Emergis is an IT leader that focuses on the health and financial services sectors. It develops and manages solutions that automate transactions and the exchange of information to increase the process efficiency and quality of service of its customers. Emergis has expertise in electronic health-related claims processing, health record systems, pharmacy management solutions, cash management and loan document processing and registration. In Canada, Emergis and its subsidiaries deliver solutions to the main insurance companies, top financial institutions, government agencies, hospitals, large corporations, real estate lawyers and notaries, and approximately 40% of all pharmacies. The Company's shares (TSX: EME) are included in the S&P/TSX Composite Index.

Certain information in this news release, in various filings with Canadian regulators, in reports to shareholders and in other communications, is forward-looking within the meaning of certain securities laws, and is subject to important risks, uncertainties and assumptions. This forward-looking information includes, among others, information with respect to the Company's objectives and the strategies to achieve those objectives, as well as information with respect to the Company's beliefs, plans, expectations, anticipations, estimates and intentions. The words "may", "could", "should", "would", "suspect", "outlook", "believe", "anticipate", "estimate", "expect", "intend", "plan", "target" and similar words and expressions are used to identify forward-looking information. The forward-looking information in this news release describes the Company's expectations as of February 8, 2007.

The results or events predicted in such forward-looking information may differ materially from actual results or events. Material factors which could cause actual results or events to differ materially from a conclusion, forecast or projection in such forward-looking information include, among others: general economic factors, adverse industry events, the adoption rate of the Company's solutions by customers and by related electronic trading communities, the delivery delays or failures, non-renewal of major contracts which expire in the near term, complexities and the timing of signing government contracts, customers developing internally the capability to perform the services which the Company performs on their behalf, the Company's response to its industry's rapid rate of change, the limited time available to capitalize on market opportunities, competition, pricing pressures, fluctuations in its operating results, its ability to make and integrate acquisitions, exposure under contract indemnities, defects in software or failures in the processing of transactions, security and privacy breaches, the Company's ability to attract and retain key personnel, its ability to protect its intellectual property, intellectual property infringement claims, and industry and government regulation.

Emergis cautions that the foregoing list of material factors is not exhaustive. When relying on the Company's forward-looking information to make decisions, investors and others should carefully consider the foregoing factors and other uncertainties and potential events. In making the forward-looking information contained in this news release, the Company does not assume any significant acquisitions, dispositions or one-time items. It does assume, however, the renewal of certain customer contracts. Every year, Emergis has major customer contracts that it needs to renew. Some of these may represent slightly more than 10% of its annual revenue. In addition, the Company also assumes the signature of contracts in new markets in the public health sector. In this regard, Emergis is pursuing large opportunities that present a very long and complex sales cycle, which substantially affect the Company's forecasting abilities. The Company has made certain assumptions regarding the timing of the realization of these opportunities which it thinks is reasonable but which may not be achieved. Furthermore, the pursuit of these larger opportunities does not ensure a linear progression of the Company's revenue and earnings, since they may involve significant up-front fees followed by reduced ongoing payments. The Company has assumed a certain progression, which may not be realized. It has also assumed that the material factors referred to in the previous paragraph will not result in such forward-looking information to differ materially from actual results or events. However, the list of these factors is not exhaustive and is subject to change and there can be no assurance that such assumptions will reflect the actual outcome of such items or factors. For additional information with respect to certain of these and other factors, refer to the risks and uncertainties section of the MD&A in the Company's 2005 Annual Report and to its 2005 Annual Information Form (risks and uncertainties) filed with Canadian regulators.

THE FORWARD-LOOKING INFORMATION CONTAINED IN THIS NEWS RELEASE REPRESENTS THE EXPECTATIONS OF EMERGIS AS AT FEBRUARY 8, 2007 AND, ACCORDINGLY, IS SUBJECT TO CHANGE AFTER SUCH DATE. HOWEVER, EMERGIS EXPRESSLY DISCLAIMS ANY INTENTION OR OBLIGATION TO UPDATE OR REVISE ANY FORWARD-LOOKING INFORMATION, WHETHER AS A RESULT OF NEW INFORMATION, FUTURE EVENTS OR OTHERWISE, EXCEPT AS REQUIRED BY APPLICABLE LAW.

 Contacts: Emergis Inc. John Gutpell 450-928-6856  

SOURCE: EMERGIS INC.

Source: MARKET WIRE

More News in this Category